Key result
Temperature lowering, potassium channel modulators, and G418 restore hERG function impaired by novel KCNH2 mutation.
Why the study?
KCNH2 loss-of-function mutations cause long QT syndrome type 2, an inherited cardiac disorder associated with life-threatening ventricular arrhythmia.
The novel KCNH2 S981fs mutation causes LQT2 via trafficking and nonsense-mediated RNA decay defects, which can be partially rescued by pharmacological interventions in vitro.
Should not yet alter LQT2 management; leaves open pharmacological rescue of KCNH2 trafficking defects for further study.
KCNH2 loss-of-function mutations cause long QT syndrome type 2 (LQT2), an inherited cardiac disorder associated with life-threatening ventricular arrhythmia. Through whole-exome sequencing, we discovered a novel AGCGACAC deletion (S981fs) in the hERG gene of an LQT2 patient. Using a heterologous expression system and patch clamping, we found that the mutant K channel had reduced cell surface expression and lower current amplitude compared to the wild type. However, functional expression was restored by lowering temperature and using potassium channel inhibitors or openers (E4031, cisapride, nicorandil). Co-immunoprecipitation experiments confirmed the assembly of mutant proteins with wild-type hERG. Confocal imaging showed decreased hERG distribution on the cell membrane in cells expressing S981fs. Notably, treatment with G418 significantly increased hERG current in wild-type/S981fs heterozygotes. In conclusion, our study identifies a novel hERG mutation leading to impaired Kv11.1 function due to trafficking and nonsense-mediated RNA decay defects. These findings shed light on the mechanisms underlying LQT2 and offer potential therapeutic avenues.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2023) studied Long QT syndrome type 2 (LQT2) (n=1). KCNH2 S981fs mutation vs. Wild-type hERG was evaluated on hERG channel function and cell surface expression. A novel KCNH2 S981fs mutation reduced hERG channel surface expression and current amplitude, which was restored by temperature lowering, potassium channel modulators, and G418.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: